Oncology

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Submitted by shcAdmin on Wed, 12/19/2018 - 15:47

Study ID

DFCI 16-716

Status

Direct Oral Anticoagulants (DOACs) versus LMWH +/- Warfarin for

Submitted by shcAdmin on Wed, 12/19/2018 - 15:47

Study ID

DFCI 16-406

Status

Feasibility and safety of avoiding granulocyte colony-stimulating

Submitted by shcAdmin on Wed, 12/19/2018 - 15:47

Study ID

DFCI 15-516

Status

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Submitted by shcAdmin on Wed, 12/19/2018 - 15:47

Study ID

DFCI 16-727

Status

A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axilla

Submitted by shcAdmin on Wed, 12/19/2018 - 15:47

Study ID

NSABP B-51

Status

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Submitted by aschwalb on Thu, 08/10/2017 - 14:39

Study ID

DFCI 16-716

Feasibility and safety of avoiding granulocyte colony-stimulating

Submitted by aschwalb on Thu, 08/10/2017 - 14:15

Study ID

DFCI 15-516

A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Submitted by aschwalb on Thu, 08/10/2017 - 14:05

Study ID

DFCI 16-727

Subscribe to Oncology